Recursion Pharmaceuticals is a buy due to AI integration in drug manufacturing and multiple clinical catalysts.
Source Post
These 2 Stocks Will Make Me A Billionaire by 2028! NASDAQ: RXRX, LON: POLB!
Value Investing with Sven Carlin, Ph.D.Apr 1, 2026
The creator is shifting his investment strategy from traditional value investing to a more technology-focused approach, aiming for significant gains by 2030. He highlights two specific stocks, Recursion Pharmaceuticals (RXRX) and Polarean (POLB), as potential multi-baggers due to AI integration and clinical catalysts.
Linked Mentions
Tickers discussed in this post
Apple was mentioned as a stock Warren Buffett started selling after the creator discussed it.
HPQ was mentioned as a stock Warren Buffett bought after the creator discussed it.
Bloom Energy was a past opportunity that could have yielded significant returns.
Linked Signals
Tracked calls opened from this post
RXRX
buy opened Apr 1, 2026
+16.75%